Published by Iain Gilbert on 21st October 2026
(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration had approved Hibsago (bepirovirsen) for the treatment of chronic hepatitis B in adults without cirrhosis, marking the first approval of an antisense oligonucleotide for the disease.
URL: http://www.digitallook.com/dl/news/story/36295013/...